Observational Study
Copyright ©The Author(s) 2020.
World J Hepatol. Oct 27, 2020; 12(10): 850-862
Published online Oct 27, 2020. doi: 10.4254/wjh.v12.i10.850
Table 1 Baseline laboratory and endoscopic findings of the enrolled patients
Variable
Liver cirrhosis with EVs
Liver cirrhosis without EVs
Control group
P value1
n909060-
Sex (M/F)62/2860/3040/200.4
Age (yr)49.6 ± 8.447.7 ± 9.746 ± 6.70.32
BMI (kg/m2)26.3 ± 2.125.8 ± 1.326.6 ± 0.90.21
ABI0.94 ± 0.091.08 ± 0.131.16 ± 0.110.001
AST (IU/L)53.7 ± 10.243.7 ± 5.631.1 ± 10.80.001
ALT (IU/L)47.2 ± 7.836.2 ± 8.530.6 ± 7.70.001
Platelet count × 10379.2 ± 21.2189.3 ± 43.2197.7 ± 18.70.001
Total cholesterol (mg/dL)177.6 ± 18.8199.2 ± 27.4210.4 ± 12.60.01
HDL (mg/dL)39.5 ± 4.344.6 ± 7.135.4 ± 5.30.004
TGs (mg/dL)135.7 ± 14.4168.8 ± 12.8180.8 ± 8.40.01
VLDL (mg/dL)16.6 ± 4.326.5 ± 5.325 ± 5.70.001
LDL (mg/dL)105.8 ± 14.5128.9 ± 20.6138.9 ± 16.50.03
FIB-44.97 ± 1.81.54 ± 0.471.51 ± 0.30.001
Platelets/SD ratio449 ± 1671375 ± 3801702 ± 2380.001
LDL/platelet count ratio1.41 ± 0.40.71 ± 0.210.75 ± 0.090.001
Child-Pugh class (n)A (26), B (46), C (18)A (88), B (2)Non-cirrhotic-
Endoscopy----
EVs----
Grade I-II, n (%)32 (35.5)---
Grade III, n (%) 42 (46.7)---
Grade IV, n (%) 16 (17.8)---
2Fundal varix, n (%) 12 (13.3)---